PAR12 ABATACEPT (CTLA4IG) IN COMBINATION WITH METHOTREXATE DEMONSTRATES SUSTAINED IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES OVER TWO YEARS IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE

✍ Scribed by T Li; R Maclean; I Nuamah; J Becker

• Book ID: 119593813
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 64 KB
• Volume: 8
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)62906-3